Immunex Enbrel
Executive Summary
More than 70,000 existing etanercept patients have registered for Enbrel's Enrollment Program, the company says. A waiting list, established for patients registering after Dec. 31, consists primarily of prospective Enbrel users. Wyeth/Immunex started the program to help ensure uninterrupted therapy for Enbrel patients during a projected temporary shortage (1"The Pink Sheet" Nov. 27, 2000, p. 3). Wyeth-Ayerst expects to break ground mid-2001 on the construction of a 1 mil. square foot Ireland plant that will likely take four to five years to complete. Enbrel's North American supply is also expected to double following the completion of a 250,000-square foot West Greenwich, R.I. facility in 2002